143 related articles for article (PubMed ID: 12518353)
1. Vascular endothelial growth factor in monitoring therapy of hepatic haemangioendothelioma.
Szymik-Kantorowicz S; Partyka L; Dembinska-Kiec A; Zdzienicka A
Med Pediatr Oncol; 2003 Mar; 40(3):196-7. PubMed ID: 12518353
[No Abstract] [Full Text] [Related]
2. Correspondence re: K. Neben et al., high plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7: 2675-2681, 2001.
Go RS; Horstman AL
Clin Cancer Res; 2002 Aug; 8(8):2750; author reply 2751. PubMed ID: 12171909
[No Abstract] [Full Text] [Related]
3. Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors.
Miyashita M; Tajiri T; Yanagi K; Shimizu T; Futami R; Sasajima K; Tokunaga A
Hepatogastroenterology; 2003; 50(50):308-9. PubMed ID: 12749209
[TBL] [Abstract][Full Text] [Related]
4. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
5. Pre-eclampsia and the microcirculation: a novel explanation.
Bates DO
Clin Sci (Lond); 2003 Apr; 104(4):413-4. PubMed ID: 12653686
[No Abstract] [Full Text] [Related]
6. [Determination of vascular endothelial growth factor (VEGF) concentration in serum of patients with colorectal carcinoma].
Broll R; Erdmann H; Windhövel U; Duchrow M; Strik MW
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):315-8. PubMed ID: 14518267
[TBL] [Abstract][Full Text] [Related]
7. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
Zhao J; Hu J; Cai J; Yang X; Yang Z
Chin Med J (Engl); 2003 May; 116(5):772-6. PubMed ID: 12875699
[TBL] [Abstract][Full Text] [Related]
9. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
[TBL] [Abstract][Full Text] [Related]
10. Levels of angiogenic peptides in sera from patients with carcinoid tumours during alpha-interferon treatment.
Nilsson A; Janson ET; Eriksson B; Larsson A
Anticancer Res; 2001; 21(6A):4087-90. PubMed ID: 11911297
[TBL] [Abstract][Full Text] [Related]
11. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
Minagawa N; Nakayama Y; Hirata K; Onitsuka K; Inoue Y; Nagata N; Itoh H
Anticancer Res; 2002; 22(5):2957-63. PubMed ID: 12530025
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?
Makin AJ; Chung NA; Silverman SH; Lip GY
Clin Sci (Lond); 2003 Apr; 104(4):397-404. PubMed ID: 12653684
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia.
Hefler L; Obermair A; Husslein P; Kainz C; Tempfer C
Acta Obstet Gynecol Scand; 2000 Jan; 79(1):77-8. PubMed ID: 10646821
[No Abstract] [Full Text] [Related]
14. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
15. Octreotide augments the effects of hepatic arterial occlusion in treating a rat liver tumor model.
Guo WJ; Zhuang JY; Bai YR; Li J; Cheng YF; Shen Z; Li WH; Zhang WZ; Cai R
Hepatogastroenterology; 2003; 50(50):349-53. PubMed ID: 12749218
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
Zachary I
IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
[TBL] [Abstract][Full Text] [Related]
17. Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.
Olaso E; Vidal-Vanaclocha F
Methods Mol Med; 2003; 85():79-86. PubMed ID: 12710199
[No Abstract] [Full Text] [Related]
18. [Thalidomide for the treatment of refractory multiple myeloma].
Kakimoto T; Hattori Y; Okamoto S
Rinsho Ketsueki; 2002 May; 43(5):345-8. PubMed ID: 12096483
[No Abstract] [Full Text] [Related]
19. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
Breier G; Heidenreich R; Gaumann A; Groot M; Licht A; Nicolaus A; Schmitz J; Reichmann E; Plate KH; Vajkoczy P
Ann Hematol; 2002; 81 Suppl 2():S71-2. PubMed ID: 12611084
[No Abstract] [Full Text] [Related]
20. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
Keyes KA; Mann L; Cox K; Treadway P; Iversen P; Chen YF; Teicher BA
Cancer Chemother Pharmacol; 2003 Apr; 51(4):321-7. PubMed ID: 12721760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]